These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25081050)

  • 41. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
    Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
    J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab.
    Patriarca F; Medeot M; Isola M; Battista ML; Sperotto A; Pipan C; Toffoletti E; Dozzo M; Michelutti A; Gregoraci G; Geromin A; Cerno M; Savignano C; Rinaldi C; Barbone F; Fanin R
    Transpl Infect Dis; 2013 Jun; 15(3):259-67. PubMed ID: 23405972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posttransplant lymphoproliferative disease, monoclonal, Epstein-Barr virus related.
    Petrovic LM
    Liver Transpl; 2001 May; 7(5):451-2. PubMed ID: 11349267
    [No Abstract]   [Full Text] [Related]  

  • 44. Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study.
    Wu M; Sun J; Zhang Y; Huang F; Zhou H; Fan Z; Xuan L; Yu G; Guo X; Dai M; Feng R; Liu Q
    Bone Marrow Transplant; 2016 Mar; 51(3):456-8. PubMed ID: 26595071
    [No Abstract]   [Full Text] [Related]  

  • 45. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
    Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
    Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.
    Milpied N; Coste-Burel M; Accard F; Moreau A; Moreau P; Garand R; Harousseau JL
    Bone Marrow Transplant; 1999 Mar; 23(6):629-30. PubMed ID: 10217196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus-associated lymphoproliferative disorder in a young child treated for Wilms tumor.
    Robison RA; Magaki S; Kheradpour A; Harder SL; Wang J; Yau D; Zuppan CW; Deisch JK
    Pediatr Hematol Oncol; 2020 Oct; 37(7):645-651. PubMed ID: 32511040
    [No Abstract]   [Full Text] [Related]  

  • 48. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
    Bar-Natan M; Nagler A
    Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060
    [No Abstract]   [Full Text] [Related]  

  • 49. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
    Brunner B; Kropshofer G; Ellemunter H; Brunner A; Mueller T; Margreiter R; Tzankov A
    Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?
    Savani BN; Pohlmann PR; Jagasia M; Chinratanalab W; Kassim A; Engelhardt B; Greer J; Schuening F; Goodman S
    Blood; 2009 Jun; 113(24):6263-4. PubMed ID: 19520823
    [No Abstract]   [Full Text] [Related]  

  • 53. Epstein-Barr virus-positive post-transplant lymphoproliferative disorder of the central nervous system, after renal transplantation with a discrepancy in viral load between peripheral blood and cerebrospinal fluid.
    Boersma MN; van der Zanden A; Laverman GD; Sanders JS; de Vries PA
    Transpl Int; 2012 Nov; 25(11):e113-6. PubMed ID: 22909403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolonged reactivation of cytomegalovirus infection following successful rituximab therapy for Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder.
    Hirokawa M; Kawabata Y; Fujishima N; Yoshioka T; Sawada K
    Int J Hematol; 2007 Oct; 86(3):291-2. PubMed ID: 17989001
    [No Abstract]   [Full Text] [Related]  

  • 55. Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT.
    Kawaguchi T; Tsukamoto S; Ohwada C; Takeuchi M; Muto T; Tanaka S; Sakai S; Takeda Y; Abe D; Sakaida E; Shimizu N; Yokote K; Iseki T; Imadome KI; Nakaseko C
    Bone Marrow Transplant; 2011 Dec; 46(12):1583-5. PubMed ID: 21278799
    [No Abstract]   [Full Text] [Related]  

  • 56. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clonal gammopathies and allogeneic stem cell transplantation.
    Sorà F; Laurenti L; Chiusolo P; De Matteis S; Leone G; Sica S
    Bone Marrow Transplant; 2008 Feb; 41(3):317. PubMed ID: 17982492
    [No Abstract]   [Full Text] [Related]  

  • 59. Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
    Kontny U; Boppana S; Jung A; Goebel H; Strahm B; Peters A; Dormann S; Werner M; Bader P; Fisch P; Niemeyer C
    Haematologica; 2005 Nov; 90 Suppl():ECR27. PubMed ID: 16266918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
    Adams B; Lazarchick J; Medina AM; Willner IR; Neville B; Murphy E; Stuart R; Costa LJ
    Am J Hematol; 2010 Aug; 85(8):627-9. PubMed ID: 20658594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.